Volume 2, Issue 11.
Anne Peters, MD covers the important topic of Risks and Benefits of SGLT-2 Inhibitor Agents in the format of case-study scenarios for the clinical practice.
Podcast (ediabetes): Play in new window | Download
Subscribe: Apple Podcasts | Android | RSS